ARCHIVES

Pathology Review Confirms Reserpine As Carcinogen

This article is from The Cancer Letter archive.

Vol. 06 No. 11 | March 14, 1980

Download PDF Visit The Full Archive

Related Articles

Interview with FDA’s Richard Pazdur

October 30, 2009

O’Leary Leads RPCI’s OR;

February 8, 2002

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

In Brief: OMB Misses Deadline On 1989 Budget, Blames Late Actin On ’88 Money Bill; Raney Heads AACE

January 8, 1988